Aytu Biopharma Inc. filed 10-Q Annual Report with SEC covering quarter ending 12/31/22, filed February 21, 2023.Full filing text available at: https://tinyurl.com/2k5asd4zNature of Business:Aytu BioPharma, Inc. (“Aytu”, the “Company” or “we”), is a pharmaceutical company focused on commercializing novel therapeutics and consumer health products. The Company operates through two business segments (i) the Rx segment, consisting of…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
